The global Gene Therapy market, valued at US$7.21 billion in 2023, is forecasted to grow at a robust CAGR of 19.4%, reaching ...

New breakthrough data from studies with Coave's ALIGATER™-engineered AAV2-based capsid coAAV-CSF-01 (S01coAAV2) demonstrates improved brain tissue transduction and safety following intra-cerebrospinal ...

GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing immunotherapies and vaccines against solid tumors and infectious diseases, announced today that the U.S. Patent and ...

To manage The Surprised, Mr. Charran recommends combining structured updates with documented communication. “Talk it out.

Net Loss: For the first quarter of 2025, the Company generated a net loss attributable to its shareholders of $19.6 million, ...

Provides ReciBioPharm's customers with access to NewBiologix's Xcell-Eng-HEK293 cell lines for advanced therapies <l ...

D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment ...

Allegro MicroSystems, Inc. ( NASDAQ: ALGM) Q4 2025 Earnings Call May 8, 2025 8:30 AM ET Jalene Hoover - Investor Relations Mike Duke - President and Chief Executive Officer Derek D’Antilio - Chief ...

"We encourage all ... to protect themselves." Officials issue urgent warning as disease-carrying insects sweep through region ...

Q1 2025 Earnings Conference Call May 8, 2025 8:30 AM ETCompany ParticipantsCarrie Gillard - Director, IRHarley Finkelstein ...

Whether it’s reducing workloads, responding more efficiently to internal client needs, or informing decisions with data, Insight+ helps corporate legal teams stay ahead of the curve in today’s ...